$QNT

Dehoff Kevin Scott purchased $900K of QNT

Dehoff Kevin Scott (Chief Strategy Officer) purchased 15,000 shares of Quantinuum Inc. (QNT) at $60.00 ($0.90M total) on 2026-06-05.

Original reporting
SEC EDGAR · Dehoff Kevin Scott
Published Jun 8, 2026, 8:31 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 8, 2026, 8:32 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$QNT
Bullish
medium confidence
Mentioned
$QNT
Relevance
6/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$QNTBullishLow
01

Why it matters

A disclosed open-market purchase of $900K may modestly improve sentiment, but it does not introduce new operational, regulatory, or financial information about Quantinuum.

02

Market read

Traders may treat this as a small bullish sentiment datapoint, but it is unlikely to be a standalone driver of price action.

03

What to watch

The article lacks any accompanying narrative (e.g., why the buy occurred), so traders should avoid extrapolating to valuation or near-term catalysts.

Relevance 6/10Novelty 8/10Timing: filed 2026-06-08 (transaction dated 2026-06-05)

Background

The article reports a SEC Form 4 insider transaction for Quantinuum (QNT) by Chief Strategy Officer Kevin Scott Dehoff.

Company-level read

Ticker impact

$QNTBullishMedium confidence
Context

Quantinuum insider Dehoff Kevin Scott bought 15,000 shares (~$900K) in an open-market Form 4 filing dated 2026-06-05.

Expected impact

Likely limited near-term impact; may slightly support sentiment rather than drive a sustained move.

Evidence & confidence

Form 4 insider buys can influence sentiment, but the article provides no new company-specific operational or financial development beyond the transaction details.

Market effects

No direct sector read-through; this is a single-company insider transaction.

None indicated.

None indicated.

Counterpoint

Insider buys can be routine portfolio rebalancing and may not reflect a change in fundamentals, especially without a 10b5-1 plan context.

Key entities

  • Quantinuum Inc.

    Subject of the Form 4 insider transaction; CSO Kevin Scott Dehoff bought 15,000 shares.

  • Kevin Scott Dehoff

    Chief Strategy Officer who executed the open-market purchase.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

HighAI 8/10

Quantinuum explained: quantum computing company and Nasdaq listing

Quantinuum, a quantum computing company, offers trapped-ion quantum computers and software for quantum chemistry, cybersecurity, and machine learning. It operates hardware and software services, targeting enterprise and research customers. The company went public on the Nasdaq in 2026, with Honeywell as a significant shareholder. Quantinuum is unique in controlling both hardware and software development internally.

$NVDAHighAI 9/10

NVIDIA's $108B AI Forecast Boosts Quantum: QNT, QUBT to Gain?

NVIDIA (NVDA) forecasted $108B in fiscal 2027 revenue, driven by AI and data center growth. This highlights infrastructure investments supporting quantum computing, benefiting companies like Quantinuum (QNT) and Quantum Computing Inc. (QUBT). QNT reported 279% YoY revenue growth, while QUBT saw a significant revenue increase and strategic acquisitions. Both companies have strong cash positions and high price targets.

$QUBTMed

Quantum Stocks Face Reality Check: QUBT, QNT Stand Out on 75%+ Upside

Quantum computing stocks face increased scrutiny as investors focus on revenue visibility and commercialization. Quantum Computing Inc. (QUBT) and Quantinuum Inc. (QNT) show commercial momentum, with QUBT reporting $5.6M in Q2 revenue and QNT raising its 2026 revenue outlook. Both stocks have analyst price targets suggesting significant upside. The macroeconomic environment remains challenging with elevated inflation and higher yields.

$CIENMed

Tradr Introduces Leveraged ETFs on Ciena, Quantinuum, Rambus, Tower Semiconductor and TTM Technologies

Tradr ETFs launched five new 2X leveraged ETFs tracking Ciena (CIEN), Quantinuum (QNT), Rambus (RMBS), Tower Semiconductor (TSEM), and TTM Technologies (TTMI). The ETFs aim to deliver 200% of the daily performance of the underlying stocks and are listed on Cboe. Tradr manages $10B in assets across 72 leveraged ETFs, targeting sophisticated investors.